Skip to main content

Alcohol Swab Market Continues To Grow Owing To the High Prevalence of the Geriatric Population in the World

 


Alcohol swab is a cotton type material saturated with 70 percent isopropyl alcohol, which is used to clean area prone to injury. Alcohol swab is also used to clean minor cuts, scrapes, bug bites, and blister. Furthermore, alcohol swab is used to clean skin before giving injection to patients. Cleaning with alcohol swab helps in the prevention of bacteria that could enter into the patient body. Alcohol swab is also used as first aid kit at home, in cars or at work. To keep alcohol swab sterile and moist until they need to be used, they are tightly sealed in aluminum paper packet and are made in variety of sizes that can be used for different types of wound. Moreover, alcohol swab is also used to disinfect scissors and tweezers. Alcohol swab should not be used in the eye or nose or on deep puncture wounds.

Global Alcohol Swab Market: Drivers

The global alcohol swab market is expected to experience significant growth over the forecast period due to increasing incidence rate of fall injuries among the people, globally. For instance, according to the Centers for Disease Control and Prevention (CDC) 2017 report, estimated 800, 000 patients are hospitalized every year due to fall injury. Furthermore, according to the same source, 3 million people are treated in emergency department due to fall injury each year, globally.

The increasing incidence of road traffic injuries among people globally is another factor driving the global alcohol swab market growth. For instance, according to the World Health Organization (WHO) February 2020 report, road traffic is the leading cause of death of children and young adults who are in the age group of 5 to 20 years. Furthermore, according to the same source, estimated 20 million to 50 million suffer from fatal injury, globally. Therefore, increasing incidence of road accidents result in increasing demand for alcohol swab to clean skin before giving injection to patients.

 

Comments

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Increasing various research activities is propelling growth of the pediatric vaccines market

  Pediatric Vaccine Market: Global Trends Over the course of the forecast period, rising public awareness of vaccinations and immunisation is anticipated to fuel market expansion for paediatric vaccines worldwide. For instance, the United States recognises January as Cervical Health Awareness Month, promoting the value of routine immunisation and screening in the fight against cancer. Global Pediatric Vaccine Market: Drivers Increasing awareness regarding vaccines and immunization among the populace is expected to boost growth of the global pediatric vaccine market over the forecast period. For instance, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded.

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering takes place and which layer of skin is affected. Global epidermolysis bullosa market is estimated to be valued at  US$ 3,